Digestive Enzymes and Mounjaro: Safety and Management Guide Written by Bolt Pharmacy Published on 14/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. As with many GLP-1-based therapies, gastrointestinal side effects such as nausea, bloating, and altered digestion are common, leading some […]
